Malvern, PA (PRWEB) May 28, 2013
North American for Continuing Medical Education, LLC (NACCME) today announced the results of a survey of oncologists, rheumatologists, managed care professionals, pharmacists, and primary care learners. The study, conducted in April 2013, focused on awareness of and need for information on biosimilar agents, with results strongly supporting the need for comprehensive education on this topic.
Over 400 health professionals participated in the survey, revealing:
- More than half of respondents said their understanding of the differences between biosimilars versus generics was only fair to poor
- Over 67% of survey participants indicated an understanding of the difference between biosimilars and reference biologics as fair or poor
- 77% of respondents rated their understanding of regulatory approval pathway for biosimilars as fair or poor
“It is crucial to get an accurate view of how health professionals view biosimilars in order to assess and address the confusion surrounding this emerging and critical area of need,” said Randy Robbin, President of NACCME. “This survey helps demonstrate the need to provide activities that improve knowledge and address areas of practice like safety monitoring and therapy selection for biosimilars.”
Among other important findings, an overwhelming 97% of survey respondents felt that continuing education on biosimilars was at least somewhat important and three-quarters of those surveyed indicated biosimilars continuing education was important or very important to their practice. Click here to download the full survey report.
NACCME distributed the survey to health professionals through its various educational communities of practice: ConsultantCME, Coalition of Rheumatology Educators (CORE), Managed Care Learning Network, Oncology Learning Network, and Pharmacy Learning Network (PLN).
About HMP Communications Holdings, LLC
HMP Communications Holdings, LLC, a collaborative formed by HMP Communications, LLC and North American Center for Continuing Medical Education, LLC (NACCME), is a leader and innovator in healthcare communications. The company produces some of the industry’s most well-respected brands of multimedia, live events and accredited continuing education (CE) programs. HMP distributes award-winning content across a wide spectrum of healthcare audiences who can access its brands anywhere, everywhere, at any time. Visit http://www.hmpholdings.com for more information.
North American Center for Continuing Medical Education, LLC, an HMP Communications Holdings, LLC company, provides the highest quality CME/CE across medical disciplines and therapeutic areas. In conjunction with top medical faculty, NACCME develops evidence‐based initiatives that target specific educational needs, assisting healthcare professionals in improving patient outcomes by bridging the gap between current and best healthcare practices. Visit http://www.naccme.com for more information.
Tags: CORE, biosimilars, reference biologics, generics, NACCME, CME